Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -143.87x is 73% above its 5-year average of -540.27x, near the high end of its 5-year range (-2041.07x–-28.53x).
40.08% above its 12-month average of -240.11x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2026 (2026-06-30): -28.53x.
INTEREST COVERAGE RATIO
-143.87x
INTEREST COVERAGE RATIO AVG TTM
-240.11x
INTEREST COVERAGE RATIO AVG 3Y
-240.11x
INTEREST COVERAGE RATIO AVG 5Y
-540.27x
INTEREST COVERAGE RATIO AVG 10Y
-760.93x
INTEREST COVERAGE RATIO AVG 15Y
-514.51x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+40.08%
CURRENT VS 3Y AVG
+40.08%
CURRENT VS 5Y AVG
+73.37%
CURRENT VS 10Y AVG
+81.09%
CURRENT VS 15Y AVG
+72.04%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.31x
median of 424 covered companies
CURRENT VS SECTOR MEDIAN
-2606.87%
vs the sector median at left
Citius Pharmaceuticals, Inc.
Market Cap
$14.03M
Interest Coverage Ratio
-143.87x
TTM Avg
-240.11x
3Y Avg
-240.11x
5Y Avg
-540.27x
Market Cap
$14.24M
Interest Coverage Ratio
-38.62x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.44M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.34M
Interest Coverage Ratio
-18.73x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.96M
Interest Coverage Ratio
-1.98x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.15M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.95M
Interest Coverage Ratio
-8.52x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | $14.03M | -143.87x | -240.11x | -240.11x | -540.27x |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.24M | -38.62x | N/A | N/A | N/A |
| Passage Bio, Inc. (PASG)vs › | $13.78M | N/A | N/A | N/A | N/A |
| IN8bio, Inc. (INAB)vs › | $13.71M | N/A | N/A | N/A | N/A |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.44M | N/A | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.34M | -18.73x | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.96M | -1.98x | N/A | N/A | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.15M | N/A | N/A | N/A | N/A |
| Optimi Health Corp. (OPTH)vs › | $12.95M | -8.52x | N/A | N/A | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.02M | N/A | N/A | N/A | N/A |
Interest Coverage
-143.9x
Debt/Equity
0.11
Current Ratio
0.84
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -28.53x |
| 2026-03-31 | -974.68x |
| 2025-12-31 | -57.99x |
| 2025-09-30 | -88.33x |
| 2025-06-30 | -51.02x |
| 2021-06-30 | -2041.07x |
| 2021-03-31 | -1063.17x |
| 2020-12-31 | -2055.55x |
| 2020-09-30 | -1197.79x |
| 2020-06-30 | -1104.57x |
| 2020-03-31 | -1113.84x |
| 2019-12-31 | -1114.49x |
| 2019-09-30 | -871.39x |
| 2019-06-30 | -1069.77x |
| 2019-03-31 | -887.20x |
| 2018-12-31 | -967.39x |
| 2018-09-30 | -951.51x |
| 2018-06-30 | -517.43x |
| 2018-03-31 | -1034.20x |
| 2017-12-31 | -958.27x |
| 2017-09-30 | -3.06x |
| 2017-06-30 | -66.92x |
| 2017-03-31 | -128.14x |
| 2016-12-31 | -210.53x |
| 2016-09-30 | -748.86x |
| 2016-06-30 | -478.39x |
| 2014-12-31 | -117.19x |
| 2014-06-30 | -18.56x |
| 2014-03-31 | -35.51x |
| 2013-12-31 | -4.45x |
| 2013-09-30 | -25.45x |
| 2013-06-30 | -3.45x |
| 2013-03-31 | -10.45x |
| 2012-12-31 | -0.81x |
| 2012-09-30 | -5.34x |
| 2012-06-30 | -9.44x |
| 2012-03-31 | -13.11x |
| 2011-12-31 | -5.90x |
| 2011-06-30 | -32.25x |
| 2011-03-31 | -46.14x |
| 2010-12-31 | -691.92x |
